64Cu-labeled CB-TE2A and Sar conjugated RGD peptide analogs for targeting angiogenesis: Comparison of their biological activity

作者: Lihui Wei , Yunpeng Ye , Thaddeus Wadas , Jason Lewis , Michael Welch

DOI:

关键词: LinkerBiodistributionPeptideBiological activityChemistryCell adhesion moleculeBinding siteIntegrinIn vivoMolecular biology

摘要: 233 Objectives: The αvβ3 integrin is a cell adhesion molecule known to be involved in stages of angiogenesis and metastasis. In this study, the chelators CB-TE2A Sarcophagine (Sar) were conjugated RGD peptide analogs cyclic RGDyK RGDfD biological properties 64Cu labeled peptides compared. Methods: CB-TE2A-c(RGDyK) Sar-c(RGDfD) with 0.1 M NH4OAc (pH = 8) at 95 °C 25 °C, respectively, for 1 h. PET biodistribution studies carried out on M21 (αvβ3-positive) M21L (αv-negative) melanoma-bearing mice 1, 2, 4 24h post injection (p.i.). Binding affinity Cu-chelator-RGD integrins was determined by competitive binding assay. Results: Biological showed higher tumor uptake compared (e.g. 4h p.i., 64Cu-CB-TE2A-c(RGDyK): 1.66±0.8 (M21) vs. 0.84±0.41 %ID/g (M21L), p=0.04). Tumor uptakes 64Cu-CB-TE2A-c(RGDyK) are than those 64Cu-Sar-c(RGDfD)(e.g., 1h 2.98±0.90 64Cu-Sar-c(RGDfD): 1.51±0.53 %ID/g, p=0.01). These differences not due differing affinities, since similar values obtained agents from assays (IC50: Cu-CB-TE2A-c(RGDyK): 6.0 nM Cu-Sar-c(RGDfD): 4.8 c(RGDyK): 3.7 nM). Compared Cu-CB-TE2A-c(RGDyK), which has longer lysine linker, Cu-Sar-c(RGDfD) closer site peptide, potentially causing partial demetallation Cu complex. slower liver clearance 64Cu-Sar-c(RGDfD) (2.63±0.53 (2h p.i.) 2.24±0.41 (24h p.i.), p=NS) (2.53±0.89 0.84±0.17 p=0.05) further evidence demetallation. Administration c(RGDyK) as block significantly reduced indicating receptor-specific accumulation. Conclusions: Both potential candidates imaging angiogenesis. For Sar-c(RGDfD), linker may needed between Cu-chelate moiety achieve optimal vivo uptake. Research Support (if any): NCI grants R24 CA86307 R01 CA93375

参考文章(48)
Vicki Brower, Tumor angiogenesis : new drugs on the block Nature Biotechnology. ,vol. 17, pp. 963- 968 ,(1999) , 10.1038/13654
Gordon C Tucker, Alpha v integrin inhibitors and cancer therapy. Current opinion in investigational drugs. ,vol. 4, pp. 722- 731 ,(2003)
J Engel, B Müller, H Kessler, G Müller, M Pfaff, R Timpl, K Tangemann, M Gurrath, Selective recognition of cyclic RGD peptides of NMR defined conformation by alpha IIb beta 3, alpha V beta 3, and alpha 5 beta 1 integrins. Journal of Biological Chemistry. ,vol. 269, pp. 20233- 20238 ,(1994) , 10.1016/S0021-9258(17)31981-6
P. A. Rocque, M. J. Welch, K. R. Zinn, S. W. Schwarz, J. M. Connett, G. W. Philpott, C. F. Meares, C. J. Anderson, Wu Guo Li Wu Guo, Copper-64-labeled antibodies for PET imaging The Journal of Nuclear Medicine. ,vol. 33, pp. 1685- 1691 ,(1992)
Katherine N. Weilbaecher, Steven L. Teitelbaum, Jennifer E. Sprague, Wei Zou, Samuel Achilefu, Hideki Kitaura, Yunpeng Ye, Carolyn J. Anderson, Noninvasive imaging of osteoclasts in parathyroid hormone-induced osteolysis using a 64Cu-labeled RGD peptide. The Journal of Nuclear Medicine. ,vol. 48, pp. 311- 318 ,(2007)
Peter Comba, Alan M. Sargeson, Lutz M. Engelhardt, Jack MacB. Harrowfield, Allan H. White, Ernst Horn, Michael R. Snow, Analysis of trigonal-prismatic and octahedral preferences in hexaamine cage complexes Inorganic Chemistry. ,vol. 24, pp. 2325- 2327 ,(1985) , 10.1021/IC00209A001
Nadine M. Di Bartolo, Alan M. Sargeson, Therese M. Donlevy, Suzanne V. Smith, Synthesis of a new cage ligand, SarAr, and its complexation with selected transition metal ions for potential use in radioimaging Journal of The Chemical Society-dalton Transactions. pp. 2303- 2309 ,(2001) , 10.1039/B103242A
Gary R. Weisman, Edward H. Wong, Daniel C. Hill, Mark E. Rogers, David P. Reed, Joseph C. Calabrese, Synthesis and transition-metal complexes of new cross-bridged tetraamine ligands Chemical Communications. pp. 947- 948 ,(1996) , 10.1039/CC9960000947